| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.08e-05 | 55 | 106 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | taste receptor activity | 2.73e-05 | 33 | 106 | 4 | GO:0008527 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.30e-05 | 187 | 106 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 7.56e-05 | 82 | 106 | 5 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 1.52e-04 | 95 | 106 | 5 | GO:0140767 | |
| GeneOntologyMolecularFunction | kynurenine-oxoglutarate transaminase activity | 1.66e-04 | 4 | 106 | 2 | GO:0016212 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 2.23e-04 | 56 | 106 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 2.39e-04 | 57 | 106 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 3.88e-04 | 27 | 106 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 9.81e-04 | 9 | 106 | 2 | GO:0017151 | |
| GeneOntologyBiologicalProcess | L-kynurenine metabolic process | 4.42e-06 | 7 | 105 | 3 | GO:0097052 | |
| GeneOntologyBiologicalProcess | kynurenine metabolic process | 2.05e-05 | 11 | 105 | 3 | GO:0070189 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 4.88e-05 | 78 | 105 | 5 | GO:0001825 | |
| GeneOntologyBiologicalProcess | L-amino acid catabolic process | 5.51e-05 | 80 | 105 | 5 | GO:0170035 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid catabolic process | 5.58e-05 | 15 | 105 | 3 | GO:0009068 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 1.22e-04 | 50 | 105 | 4 | GO:0050912 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.52e-04 | 99 | 105 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | organelle fission | NCAPD3 TOPBP1 CIT KIF20B AKAP8L FANCD2 PRMT5 CENPI KDR NUDC TDRD12 | 1.58e-04 | 571 | 105 | 11 | GO:0048285 |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.83e-04 | 103 | 105 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | alpha-amino acid catabolic process | 1.92e-04 | 104 | 105 | 5 | GO:1901606 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 2.28e-04 | 108 | 105 | 5 | GO:0035019 | |
| GeneOntologyCellularComponent | motile cilium | PRAMEF7 PRAMEF5 DNAH2 PRAMEF12 SSX8P PRAMEF8 DNAH1 VPS13A TAS2R20 TAS2R30 PRAMEF6 | 1.91e-06 | 355 | 106 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.95e-06 | 47 | 106 | 5 | GO:0031462 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | PRAMEF7 AMFR PRAMEF5 PRAMEF12 PRAMEF8 FBH1 ANAPC1 PRAMEF6 ARMC8 | 7.69e-05 | 352 | 106 | 9 | GO:0000151 |
| GeneOntologyCellularComponent | acrosomal vesicle | 8.71e-05 | 206 | 106 | 7 | GO:0001669 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.04e-04 | 212 | 106 | 7 | GO:0031461 | |
| GeneOntologyCellularComponent | cilium | CYLD PRAMEF7 PRAMEF5 DNAH2 PRAMEF12 SSX8P PRAMEF8 DNAH1 VPS13A TRPV4 TAS2R20 TAS2R30 PRAMEF6 | 6.16e-04 | 898 | 106 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | inner dynein arm | 1.12e-03 | 10 | 106 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | transferase complex | PRAMEF7 AMFR PRAMEF5 PRAMEF12 PRAMEF8 YEATS2 FBH1 ANAPC1 PRMT5 KMT2A MMS19 PRAMEF6 ARMC8 | 1.17e-03 | 963 | 106 | 13 | GO:1990234 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | PRAMEF7 AMFR PRAMEF5 PRAMEF12 PRAMEF8 YEATS2 FBH1 AGO3 ANAPC1 DROSHA MMS19 PRAMEF6 ARMC8 | 1.27e-03 | 972 | 106 | 13 | GO:0140535 |
| MousePheno | abnormal jejunum morphology | 1.49e-07 | 41 | 84 | 6 | MP:0004002 | |
| MousePheno | abnormal spermatogonia proliferation | 3.46e-07 | 47 | 84 | 6 | MP:0002685 | |
| MousePheno | abnormal cecum morphology | 2.82e-05 | 99 | 84 | 6 | MP:0000494 | |
| MousePheno | abnormal duodenum morphology | 4.01e-05 | 64 | 84 | 5 | MP:0003271 | |
| MousePheno | abnormal lens morphology | PRAMEF7 PRAMEF5 GPX1 BMS1 PRAMEF12 PRAMEF8 PPAT FANCD2 ANAPC1 GLRX PLXNA4 KYNU GOT2 PRAMEF6 | 6.57e-05 | 699 | 84 | 14 | MP:0001303 |
| MousePheno | enlarged urinary bladder | 6.88e-05 | 116 | 84 | 6 | MP:0011874 | |
| MousePheno | increased susceptibility to noise-induced hearing loss | 7.26e-05 | 14 | 84 | 3 | MP:0004597 | |
| MousePheno | cryptophthalmos | 1.07e-04 | 3 | 84 | 2 | MP:0005242 | |
| MousePheno | increased cellular sensitivity to oxidative stress | 1.37e-04 | 44 | 84 | 4 | MP:0008412 | |
| MousePheno | increased male germ cell apoptosis | 1.39e-04 | 189 | 84 | 7 | MP:0014052 | |
| MousePheno | cataract | PRAMEF7 PRAMEF5 GPX1 BMS1 PRAMEF12 PRAMEF8 PPAT PLXNA4 KYNU GOT2 PRAMEF6 | 1.83e-04 | 497 | 84 | 11 | MP:0001304 |
| MousePheno | abnormal large intestine morphology | 2.48e-04 | 276 | 84 | 8 | MP:0000489 | |
| MousePheno | abnormal anterior eye segment morphology | PRAMEF7 PRAMEF5 GPX1 BMS1 PRAMEF12 PRAMEF8 PPAT FREM1 FANCD2 ANAPC1 GLRX LTN1 PLXNA4 TRPV4 KYNU GOT2 PRAMEF6 | 2.95e-04 | 1117 | 84 | 17 | MP:0005193 |
| MousePheno | abnormal circulating amylase level | 3.48e-04 | 156 | 84 | 6 | MP:0008804 | |
| MousePheno | decreased hematopoietic stem cell number | 3.76e-04 | 57 | 84 | 4 | MP:0004810 | |
| Domain | PRAME_family | 4.58e-08 | 19 | 101 | 5 | IPR026271 | |
| Pathway | WP_IDO_METABOLIC_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M48109 | |
| Pubmed | 2.62e-10 | 28 | 107 | 6 | 25089626 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.53e-10 | 202 | 107 | 10 | 33005030 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.51e-09 | 17 | 107 | 5 | 23565261 | |
| Pubmed | 1.51e-09 | 17 | 107 | 5 | 37781892 | ||
| Pubmed | 2.08e-09 | 18 | 107 | 5 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 2.08e-09 | 18 | 107 | 5 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 2.08e-09 | 18 | 107 | 5 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 2.08e-09 | 18 | 107 | 5 | 29731491 | |
| Pubmed | 2.08e-09 | 18 | 107 | 5 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 2.82e-09 | 19 | 107 | 5 | 28604677 | |
| Pubmed | 3.75e-09 | 20 | 107 | 5 | 26694250 | ||
| Pubmed | 3.75e-09 | 20 | 107 | 5 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 3.75e-09 | 20 | 107 | 5 | 21425410 | |
| Pubmed | 6.33e-09 | 22 | 107 | 5 | 31729367 | ||
| Pubmed | 8.07e-09 | 23 | 107 | 5 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.27e-08 | 25 | 107 | 5 | 12620990 | |
| Pubmed | 1.27e-08 | 25 | 107 | 5 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 1.57e-08 | 26 | 107 | 5 | 18500982 | |
| Pubmed | 2.90e-08 | 59 | 107 | 6 | 11279525 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 3.36e-08 | 30 | 107 | 5 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 4.73e-08 | 32 | 107 | 5 | 37889087 | |
| Pubmed | 7.57e-08 | 35 | 107 | 5 | 19389355 | ||
| Pubmed | AMFR BMS1 APLP2 SLC1A3 AKAP8L TMEM33 FANCD2 GK PRMT5 LTN1 VPS13A EIF5 MMS19 | 1.24e-07 | 657 | 107 | 13 | 36180527 | |
| Pubmed | 3.11e-07 | 46 | 107 | 5 | 17287250 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 4.76e-07 | 50 | 107 | 5 | 31806660 | |
| Pubmed | 5.65e-07 | 408 | 107 | 10 | 33766124 | ||
| Pubmed | WBP2 PRAMEF7 PRAMEF5 PRAMEF12 EDC4 PRAMEF8 NUDC NLRP4 PRAMEF6 | 8.02e-07 | 326 | 107 | 9 | 17015433 | |
| Pubmed | 1.01e-06 | 58 | 107 | 5 | 31598710 | ||
| Pubmed | CYLD DIS3L GPX1 BCL11A AKAP8L FANCD2 YEATS2 ZNF469 BCL11B AGO3 ANAPC1 DROSHA LTN1 MMS19 UNC5D | 1.72e-06 | 1116 | 107 | 15 | 31753913 | |
| Pubmed | Dorsal turning of motor corticospinal axons at the pyramidal decussation requires plexin signaling. | 2.35e-06 | 9 | 107 | 3 | 18727829 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | PRAMEF7 PRAMEF5 PRAMEF12 PRAMEF8 AGO3 DROSHA KDR NLRP4 PRAMEF6 | 6.83e-06 | 424 | 107 | 9 | 21731673 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCAPD3 ACACA U2SURP BMS1 APLP2 EDC4 PPAT PAICS TMEM33 FANCD2 ANAPC1 PRMT5 EIF5 NUDC GOT2 ARMC8 | 7.48e-06 | 1425 | 107 | 16 | 30948266 |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20346443 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12196208 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19136612 | ||
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 9.38e-06 | 2 | 107 | 2 | 15465497 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17240369 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28663579 | ||
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 9.38e-06 | 2 | 107 | 2 | 11719382 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24619647 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23575676 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 9.54e-06 | 157 | 107 | 6 | 30686591 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF7 AMFR PRSS2 PRAMEF5 PRAMEF12 PRAMEF8 YEATS2 LTN1 MMS19 PRAMEF6 | 9.99e-06 | 564 | 107 | 10 | 21565611 |
| Pubmed | 1.16e-05 | 453 | 107 | 9 | 29656893 | ||
| Pubmed | 1.25e-05 | 347 | 107 | 8 | 16033648 | ||
| Pubmed | NCAPD3 WRN BMS1 TOPBP1 APLP2 EDC4 CIT KIF20B AKAP8L ANAPC1 DROSHA PRMT5 LTN1 EIF5 KMT2A ARMC8 | 1.38e-05 | 1497 | 107 | 16 | 31527615 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | AMFR DIS3L SARM1 GPX1 BMS1 MYO18A CIT SLC1A3 AKAP8L FANCD2 LTN1 | 2.17e-05 | 754 | 107 | 11 | 33060197 |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18523013 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10557082 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11073713 | ||
| Pubmed | The origin of trypsin: evidence for multiple gene duplications in trypsins. | 2.81e-05 | 3 | 107 | 2 | 9732462 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26140362 | ||
| Pubmed | Role of NRF-1 in bidirectional transcription of the human GPAT-AIRC purine biosynthesis locus. | 2.81e-05 | 3 | 107 | 2 | 9108165 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 38517158 | ||
| Pubmed | Regulation of pulmonary fibrosis by chemokine receptor CXCR3. | 2.81e-05 | 3 | 107 | 2 | 15254596 | |
| Pubmed | AMFR NCAPD3 BMS1 EDC4 PAICS AKAP8L TMEM33 FANCD2 PRMT5 LTN1 KMT2A MMS19 NUDC RPA3 ARMC8 | 3.53e-05 | 1440 | 107 | 15 | 30833792 | |
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 3.62e-05 | 21 | 107 | 3 | 27723720 | |
| Pubmed | Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c. | 4.18e-05 | 22 | 107 | 3 | 26182416 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.18e-05 | 212 | 107 | 6 | 33853758 | |
| Pubmed | 5.19e-05 | 549 | 107 | 9 | 38280479 | ||
| Pubmed | The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia. | 5.60e-05 | 4 | 107 | 2 | 29618029 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 23221805 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 11306810 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 15721238 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 36495293 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 5.60e-05 | 4 | 107 | 2 | 25518740 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 23064648 | ||
| Pubmed | Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. | 5.60e-05 | 4 | 107 | 2 | 20482848 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 18563433 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 35766181 | ||
| Pubmed | Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. | 5.60e-05 | 4 | 107 | 2 | 17581865 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10744719 | ||
| Pubmed | 6.35e-05 | 220 | 107 | 6 | 24550385 | ||
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 8.24e-05 | 453 | 107 | 8 | 27113764 | |
| Pubmed | Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature. | 9.32e-05 | 5 | 107 | 2 | 28542220 | |
| Pubmed | Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development. | 9.32e-05 | 5 | 107 | 2 | 17251066 | |
| Pubmed | Novel frem1-related mouse phenotypes and evidence of genetic interactions with gata4 and slit3. | 9.32e-05 | 5 | 107 | 2 | 23536828 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 15965237 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 17596926 | ||
| Pubmed | 1.08e-04 | 30 | 107 | 3 | 19401682 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | WBP2 PRAMEF7 AMFR PRAMEF5 PRAMEF12 EDC4 PRAMEF8 CIT AGO3 PRMT5 VPS13A EEF1AKMT1 PRAMEF6 | 1.17e-04 | 1242 | 107 | 13 | 30973865 |
| Pubmed | 1.20e-04 | 31 | 107 | 3 | 19690177 | ||
| Pubmed | CYLD DIS3L BMS1 MYO18A BCL11A EDC4 CIT AKAP8L YEATS2 AGO3 KMT2A USP27X NUDC RPA3 | 1.26e-04 | 1429 | 107 | 14 | 35140242 | |
| Pubmed | CYLD PRAMEF7 PRAMEF5 PRAMEF12 PRAMEF8 SLC1A3 PAICS LTN1 ITPRIP NLRP4 PRAMEF6 ARMC8 | 1.29e-04 | 1084 | 107 | 12 | 11544199 | |
| Pubmed | Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. | 1.40e-04 | 6 | 107 | 2 | 20010807 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 24700879 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 20445064 | ||
| Pubmed | The Amyloid Precursor Protein Is a Conserved Receptor for Slit to Mediate Axon Guidance. | 1.40e-04 | 6 | 107 | 2 | 28785723 | |
| Pubmed | Craniofacial consequences of connective tissue disorders in mice. | 1.40e-04 | 6 | 107 | 2 | 6391574 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 25644401 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 23644491 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 8106516 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 17462874 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACACA CAPN2 GPX1 EDC4 PPAT PAICS FANCD2 PRMT5 EIF5 MMS19 GMPPB NUDC RPA3 KYNU | 1.52e-04 | 1455 | 107 | 14 | 22863883 |
| Pubmed | 1.86e-04 | 650 | 107 | 9 | 38777146 | ||
| Pubmed | CYLD BCL11A EDC4 CIT SLC1A3 CNTNAP5 BCL11B AGO3 ANAPC1 UNC79 ARMC8 | 1.91e-04 | 963 | 107 | 11 | 28671696 | |
| Pubmed | Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration. | 1.95e-04 | 7 | 107 | 2 | 34450065 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 1.95e-04 | 7 | 107 | 2 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 1.95e-04 | 7 | 107 | 2 | 19655386 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 15385965 | ||
| Interaction | LRRC31 interactions | 5.55e-08 | 205 | 97 | 10 | int:LRRC31 | |
| Interaction | PFAS interactions | 1.23e-05 | 160 | 97 | 7 | int:PFAS | |
| Cytoband | 1p36.21 | 3.77e-07 | 63 | 106 | 5 | 1p36.21 | |
| GeneFamily | PRAME family | 3.25e-08 | 24 | 71 | 5 | 686 | |
| GeneFamily | Taste 2 receptors | 4.79e-04 | 39 | 71 | 3 | 1162 | |
| GeneFamily | Plexins | 5.38e-04 | 9 | 71 | 2 | 683 | |
| GeneFamily | C2 domain containing|Calpains | 1.54e-03 | 15 | 71 | 2 | 975 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 2.23e-03 | 18 | 71 | 2 | 1269 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 2.16e-07 | 34 | 103 | 5 | MM955 | |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF7 PRSS2 PRAMEF5 DIS3L PRAMEF12 BCL11A PRAMEF8 PAICS PRAMEF6 | 5.50e-07 | 245 | 103 | 9 | MM735 |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.50e-06 | 98 | 103 | 6 | MM592 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 3.02e-06 | 57 | 103 | 5 | MM1262 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 1.72e-05 | 81 | 103 | 5 | MM938 | |
| Coexpression | GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP | 2.99e-05 | 151 | 103 | 6 | M6922 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 NCAPD3 FRAS1 U2SURP WRN TOPBP1 PPAT SLC1A3 PAICS KIF20B TMEM33 BGN YEATS2 FBH1 AGO3 ANAPC1 CENPI | 3.31e-05 | 1407 | 103 | 17 | M14427 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | NCAPD3 U2SURP WRN PPAT CIT PAICS KIF20B FANCD2 FBH1 KCNH2 PRMT5 GLRX NUDC RPA3 GOT2 ARMC8 | 3.56e-05 | 1271 | 103 | 16 | M39197 |
| Coexpression | INGRAM_SHH_TARGETS_UP | 3.59e-05 | 156 | 103 | 6 | MM550 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 4.32e-05 | 98 | 103 | 5 | MM3656 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 4.32e-05 | 98 | 103 | 5 | MM942 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 8.52e-05 | 113 | 103 | 5 | M39153 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.97e-06 | 177 | 105 | 6 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-06 | 184 | 105 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-06 | 184 | 105 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-06 | 184 | 105 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-06 | 195 | 105 | 6 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.92e-06 | 195 | 105 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.92e-06 | 195 | 105 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.12e-06 | 196 | 105 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.33e-06 | 197 | 105 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | IPF-Myeloid-Macrophage|IPF / Disease state, Lineage and Cell class | 7.33e-06 | 197 | 105 | 6 | a2ffb33c7cad6be43cbb8ed9a91338923cc07db4 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 7.99e-06 | 200 | 105 | 6 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.99e-06 | 200 | 105 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.99e-06 | 200 | 105 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.99e-06 | 200 | 105 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 145 | 105 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 160 | 105 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-05 | 162 | 105 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 163 | 105 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-05 | 168 | 105 | 5 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-05 | 168 | 105 | 5 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 169 | 105 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-05 | 171 | 105 | 5 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 178 | 105 | 5 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 178 | 105 | 5 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 179 | 105 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-05 | 181 | 105 | 5 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.14e-05 | 182 | 105 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-05 | 183 | 105 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-05 | 183 | 105 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 7.51e-05 | 184 | 105 | 5 | b81a2a95944cee8fec13d63dc0d95496e67aa937 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 184 | 105 | 5 | a12a6a481e78adc62da1904431f62b119f70b15f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 7.71e-05 | 185 | 105 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 189 | 105 | 5 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 8.53e-05 | 189 | 105 | 5 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-05 | 189 | 105 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.74e-05 | 190 | 105 | 5 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.74e-05 | 190 | 105 | 5 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.74e-05 | 190 | 105 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.74e-05 | 190 | 105 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 191 | 105 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 192 | 105 | 5 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 192 | 105 | 5 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-05 | 193 | 105 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 193 | 105 | 5 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 193 | 105 | 5 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 193 | 105 | 5 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.64e-05 | 194 | 105 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Myeloid-TRAM2|Control / Condition, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | d951dd1274d3ff1ac30671ec4153a4a8bc97b53f | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 9.87e-05 | 195 | 105 | 5 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.87e-05 | 195 | 105 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 9.87e-05 | 195 | 105 | 5 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.87e-05 | 195 | 105 | 5 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.87e-05 | 195 | 105 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | ef2304acb01638df197f42dcc3db8c5867f4dc17 | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 9.87e-05 | 195 | 105 | 5 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | 5ed495941b80221206b8a9a86d92221ab8ba6682 | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 9.87e-05 | 195 | 105 | 5 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.01e-04 | 196 | 105 | 5 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 196 | 105 | 5 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 196 | 105 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 196 | 105 | 5 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Control-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class | 1.01e-04 | 196 | 105 | 5 | e2c2a30fa3ee3034fbde5335be169e880dde622d | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.01e-04 | 196 | 105 | 5 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 196 | 105 | 5 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 196 | 105 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 197 | 105 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 197 | 105 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 197 | 105 | 5 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | distal-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 198 | 105 | 5 | a8093144cbe3069c25a6c1f1c94218a115da8748 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 198 | 105 | 5 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 198 | 105 | 5 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-04 | 198 | 105 | 5 | 76db943db8b5483754f38e4c6af7f5955cec420c | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 198 | 105 | 5 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | COVID-19-Myeloid-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.09e-04 | 199 | 105 | 5 | e1c85ca85fa22c4a4fa1bbdf55304bf3628485ee | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.09e-04 | 199 | 105 | 5 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | f544229f471b4717166dd4b588399afe45cc31b5 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 1.09e-04 | 199 | 105 | 5 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.09e-04 | 199 | 105 | 5 | bcf7d15b6a08b24e7dd0ce106817659cb976f833 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 1.09e-04 | 199 | 105 | 5 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | mLN-(2)_B_cell-(23)_Follicular_B_cell|mLN / shred on region, Cell_type, and subtype | 1.11e-04 | 200 | 105 | 5 | 659b49eeeb3e96b0a52663e60336ca4d76c83cfc | |
| ToppCell | Parenchyma_COVID-19-Immune-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.11e-04 | 200 | 105 | 5 | fe27d56a05151049a64e35db5a144ff7952e6902 | |
| ToppCell | mLN-B_cell-Follicular_B_cell|mLN / Region, Cell class and subclass | 1.11e-04 | 200 | 105 | 5 | 7f5dbd06f8643230dba45d6fa0258a13cb71f681 | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 1.11e-04 | 200 | 105 | 5 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-04 | 200 | 105 | 5 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.16e-04 | 106 | 105 | 4 | 4bee154c8b984338c06f73bd6e3fb26abce0bd72 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 127 | 105 | 4 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.54e-04 | 130 | 105 | 4 | ab141d91988a5de6d092757377a53f7de3707556 | |
| Computational | Genes in the cancer module 177. | 9.52e-06 | 101 | 53 | 6 | MODULE_177 | |
| Computational | Neighborhood of RAD54L | 1.60e-04 | 105 | 53 | 5 | MORF_RAD54L | |
| Disease | breast angiosarcoma (is_implicated_in) | 3.07e-05 | 3 | 95 | 2 | DOID:4511 (is_implicated_in) | |
| Disease | corneal hysteresis | 3.54e-05 | 20 | 95 | 3 | EFO_0010066 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 6.13e-05 | 4 | 95 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | brain glioma (is_marker_for) | 1.02e-04 | 5 | 95 | 2 | DOID:0060108 (is_marker_for) | |
| Disease | glutamate measurement | 1.11e-04 | 29 | 95 | 3 | EFO_0010487 | |
| Disease | neurodegenerative disease (biomarker_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:1289 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.88e-04 | 163 | 95 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | hemoglobin subunit zeta measurement | 2.13e-04 | 7 | 95 | 2 | EFO_0801670 | |
| Disease | Unilateral agenesis of kidney | 2.84e-04 | 8 | 95 | 2 | C0266294 | |
| Disease | Malignant Head and Neck Neoplasm | 3.89e-04 | 44 | 95 | 3 | C0278996 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 6.63e-04 | 12 | 95 | 2 | DOID:3963 (is_marker_for) | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-03 | 16 | 95 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-03 | 16 | 95 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551479 | |
| Disease | sickle cell anemia (is_implicated_in) | 1.20e-03 | 16 | 95 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-03 | 16 | 95 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-03 | 16 | 95 | 2 | C0025237 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.26e-03 | 145 | 95 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 1.35e-03 | 17 | 95 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Van Buchem disease | 1.35e-03 | 17 | 95 | 2 | C0432272 | |
| Disease | Hemangiosarcoma | 1.52e-03 | 18 | 95 | 2 | C0018923 | |
| Disease | Osteochondrodysplasias | 1.69e-03 | 19 | 95 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 1.69e-03 | 19 | 95 | 2 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.88e-03 | 20 | 95 | 2 | C0026760 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.21e-03 | 169 | 95 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.27e-03 | 22 | 95 | 2 | C3711387 | |
| Disease | Myocardial Ischemia | 2.55e-03 | 176 | 95 | 4 | C0151744 | |
| Disease | glioblastoma (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | Acute monocytic leukemia | 3.17e-03 | 26 | 95 | 2 | C0023465 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCKVFEMIINPGDNV | 121 | Q8N5Z0 | |
| VVEQMLFKVLPGLLC | 181 | P59826 | |
| NTKKLNCFPVLMGIV | 886 | Q8WWZ4 | |
| EPNFMLFEKCEVNGA | 106 | P07203 | |
| LKDNTCVVEFQFMLP | 1171 | Q13085 | |
| QQKFIAMFICSEIPI | 321 | Q6MZZ7 | |
| MGKPIKLLANCFQVE | 26 | Q9H9G7 | |
| KVALQMPEGLLLFAC | 76 | Q9BZG8 | |
| AANPVEFMCQAFKIV | 276 | Q6ZUJ8 | |
| EFLNICQVHGFPKIM | 166 | Q14692 | |
| FLMDGQELICLPQVF | 81 | Q96NX9 | |
| FVLFEECSQPALMKI | 56 | O14578 | |
| ACDLFIPMQFGIIQK | 486 | Q9ULX6 | |
| ILQGPCEQISKVFLM | 246 | P50749 | |
| VVLPAFEKSCQAMFQ | 1121 | Q6P2E9 | |
| GKFMPFNLIPVIQCD | 341 | Q8IWB1 | |
| FLIGFCEILQKMNIT | 1046 | O94822 | |
| RGLFMNSEFLPVVKC | 1836 | Q9H1A4 | |
| AVAEPQIAMFCGKLN | 46 | Q06481 | |
| VIQGMCKAVPFVQVF | 96 | Q8N907 | |
| CPIKINQFEGHFMKL | 1681 | P23467 | |
| EFQLCNNEKVFLMDP | 3661 | Q86XX4 | |
| DKQLCEFFGIPMEIL | 216 | Q14409 | |
| PLNGFKDQLCSLVFM | 436 | Q96T76 | |
| PLQIFDKICLNILFM | 216 | Q5W064 | |
| QPKDFLTGMCLFLQS | 221 | Q9Y5P6 | |
| IDMNAVLKGFPECLQ | 711 | Q12809 | |
| CQMNFPLGDILIFIE | 51 | Q9H165 | |
| MKFLTCTQGPQEGLF | 341 | A0A0J9YX94 | |
| VINDTAMLCKAPGIF | 1071 | P51805 | |
| EPLFSLFCAIKQQME | 1456 | Q9HCM2 | |
| LFCAIKQQMEKGPID | 1461 | Q9HCM2 | |
| VIHQFFCDVPQMLKL | 171 | Q9UGF5 | |
| NITKVGVNDFCPMGF | 311 | P21810 | |
| PEKCLFGAMLNIAAV | 51 | Q6UX65 | |
| PNQIPKAAFMAVFIL | 291 | Q5H8C1 | |
| KEFFQGCIMQPVKDL | 126 | Q96Q89 | |
| QAAELLGVKMCTFVP | 176 | Q8WVE0 | |
| CLFEMQDPAFVKQAV | 556 | Q96MN2 | |
| TNFPVLIQFVNGMKC | 71 | Q02509 | |
| GQQPLMVILDLCFKN | 141 | O95522 | |
| FKNLVDINFVCAMGP | 2331 | Q9P2D7 | |
| MQALKCFSVLAFENP | 206 | Q8IUR7 | |
| QDMLDGFIKKFVLCP | 86 | P55010 | |
| IMNIVLSQPCGKIFV | 656 | Q8NFZ0 | |
| CPSKAIFFKNVMNLI | 231 | Q96RP8 | |
| CQMNFPLGDILVFIE | 61 | Q9C0K0 | |
| NACVKNKGQFEMVIP | 66 | Q8N1I0 | |
| PELKGIIFMQTACQA | 76 | Q8TF46 | |
| NMFPPNLVEACFKQF | 176 | P43003 | |
| MAQEFVNCKIQPGKV | 1 | P35754 | |
| DKQLCEFFGIPMEIL | 216 | P32189 | |
| GAVAKQGFDFLCMPV | 31 | O14744 | |
| VEKMEFPAVTFCNLN | 101 | Q9NY37 | |
| CGNILPSDIMDFVLK | 2841 | Q03164 | |
| VPFVNGVLFCKMRLL | 21 | Q5T8I3 | |
| FGNAVNTRILKCMIP | 121 | Q92674 | |
| CLIIQMPRFGKDFKL | 751 | Q9NQC7 | |
| LCGMDFPIKTNLEIV | 216 | Q02742 | |
| FKMPCQLHQVIVARF | 636 | P17655 | |
| CFGLKLELGMPVQTQ | 121 | Q9P225 | |
| ILFFVLNDMGCIDPM | 3616 | Q9P225 | |
| RQQPFMVFIDLCLKN | 141 | Q5VWM4 | |
| AMFSCIVNFQLPKEE | 166 | W5XKT8 | |
| IKAFQGCMRLIFIDN | 506 | Q8WYK1 | |
| GCMRLIFIDNQPKDL | 511 | Q8WYK1 | |
| FVEAFLKQCMPLLDF | 1301 | Q9BXW9 | |
| MPAFEAIFFKCQILL | 311 | Q3ZCN5 | |
| IQEFCPNTKMLLVGC | 121 | P61587 | |
| FFCDILPVMKLSCIN | 176 | Q8NGY7 | |
| PKEIVLMLCQAFGII | 256 | P59543 | |
| NFGRLEKQPVFMFCQ | 251 | P59541 | |
| EKQPVFMFCQAIIFS | 256 | P59541 | |
| NFGRLEKQPVFMFCQ | 251 | P0DTE0 | |
| EKQPVFMFCQAIIFS | 256 | P0DTE0 | |
| NLPAMFGDVKFVCVG | 51 | O95045 | |
| MPENFCVKGLELFSL | 636 | Q9NRR4 | |
| PLKITSNMFCVGFLE | 176 | Q8NHM4 | |
| FPNKVVLMCIIINGL | 391 | Q8WV83 | |
| MLQLLVLKIEDPGCF | 1 | Q587J7 | |
| VLQLKMSNIPACFLG | 606 | Q14191 | |
| MLAQFIDKPVCFVGR | 16 | P35244 | |
| PFCVNFRLKGKDMVV | 186 | Q9Y266 | |
| LSQVAGMPVFLKCEN | 26 | Q96GA7 | |
| PRKNDIGDAMVFCLN | 551 | O15042 | |
| DQIGMFCFTGLKPEQ | 376 | P00505 | |
| MLVAKLIQCIVFGPL | 96 | Q9UKV5 | |
| KRNPVMFFQHFIECI | 1046 | P42695 | |
| LPQNCTLVDMKIEFG | 181 | P22234 | |
| RQQPFMVFIDLCLKN | 141 | Q5VXH5 | |
| KMPCLEAFQAVLDGL | 71 | Q5VXH4 | |
| QLTMNKLPVVACFHF | 296 | A6NNY8 | |
| EVPCFNVNAQLKPME | 1306 | Q96RL7 | |
| GICIAFKDIMPFSAQ | 236 | Q7RTX1 | |
| NFVLVLSPGALDKCM | 616 | Q6SZW1 | |
| LGFNVTLPPFMCNKQ | 61 | Q7RTT4 | |
| FIFLQLETAKEPCMA | 46 | Q9UNG2 | |
| KMPCLEAFQAVLDGL | 71 | Q5TYX0 | |
| CFMGINIPTKEELIA | 426 | Q06203 | |
| FCEPLQLSMKGIDVF | 206 | Q8IZ13 | |
| PGKITNNMFCVGFLE | 176 | P07478 | |
| KARPAMQIFFKCNGE | 76 | Q6UXZ4 | |
| LSTKFEMQDLCFLGP | 3021 | Q96JG9 | |
| MFPVFSGCFQELQEK | 1 | Q9BY31 | |
| PLMVIVEFCKFGNLS | 911 | P35968 | |
| NMEDFKCPIFLGCII | 191 | Q92547 | |
| VMCNDLFKVNPFQLQ | 71 | O95411 | |
| DLFMKKCPGVNSLFI | 531 | Q9HBA0 | |
| ILKFIACNEIFLMPA | 156 | P57088 | |
| ICNIPFLDFLTNKHM | 1401 | Q9ULM3 | |
| CQKRDQLFVPIMFAL | 146 | B6A8C7 | |
| GFQFPKPEMICQLEN | 51 | Q5FWF6 | |
| FEEPDILFNMLNCLK | 966 | Q9P2D8 | |
| LMKDCEIKQPVFGAN | 76 | Q969T9 | |
| MDNKLQLIPGVCGFR | 316 | Q16719 |